CNBC August 6, 2019
Christina Farr

KEY POINTS
  • CVS and Walgreens say PillPack is requesting transfers of prescriptions for patients who haven’t provided consent.
  • The conflict started heating up immediately after Amazon purchased PillPack in mid-2018 for $753 million.
  • It’s part of a broader challenge that Amazon faces as it attempts to upend the traditional pharmacy market and become a major player in prescription drug delivery.

As Amazon bolsters its PillPack business to take on the prescription drug market, industry stalwarts CVS and Walgreens are vigorously defending their turf, setting up a protracted battle between the old guard and the new.

Amazon bought internet pharmacy PillPack last year, a deal that sent shares of pharmacy companies...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Provider, Retailer
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
Cerevel Parkinson’s data adds lustre to AbbVie acquisition
Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer
Pharma Pulse 4/19/24: The Health and Healthcare of Gen-Z, Long-Acting Drugs May Revolutionize HIV Prevention/Treatment & more
Recursion, Canaan, Metsera and more—Chutes & Ladders

Share This Article